Massachusetts Financial Services Co. MA Has $27.93 Million Stock Holdings in Tempus AI, Inc. (NASDAQ:TEM)

Massachusetts Financial Services Co. MA grew its holdings in Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 92.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 578,890 shares of the company's stock after purchasing an additional 278,311 shares during the period. Massachusetts Financial Services Co. MA owned about 0.34% of Tempus AI worth $27,926,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Franklin Resources Inc. increased its holdings in Tempus AI by 240.5% in the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock worth $93,251,000 after buying an additional 1,950,862 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in Tempus AI by 86,947.2% in the fourth quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock worth $55,836,000 after buying an additional 1,651,996 shares during the last quarter. Norges Bank acquired a new position in Tempus AI in the fourth quarter worth approximately $34,681,000. Sumitomo Mitsui Trust Group Inc. increased its holdings in Tempus AI by 31.4% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock worth $205,284,000 after buying an additional 1,016,384 shares during the last quarter. Finally, Mariner LLC acquired a new position in Tempus AI in the fourth quarter worth approximately $31,187,000. Institutional investors and hedge funds own 24.22% of the company's stock.

Insider Activity

In other Tempus AI news, Director Theodore Leonsis sold 205,847 shares of the firm's stock in a transaction dated Wednesday, June 11th. The stock was sold at an average price of $67.66, for a total transaction of $13,927,608.02. Following the transaction, the director owned 15,511 shares in the company, valued at approximately $1,049,474.26. This trade represents a 92.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Ryan Fukushima sold 20,000 shares of the firm's stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $52.36, for a total value of $1,047,200.00. Following the transaction, the chief operating officer owned 884,460 shares in the company, valued at approximately $46,310,325.60. This trade represents a 2.21% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 612,522 shares of company stock valued at $41,600,238. Insiders own 27.60% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on TEM shares. Morgan Stanley upped their target price on Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. BTIG Research started coverage on Tempus AI in a research report on Monday, April 21st. They set a "buy" rating and a $60.00 target price for the company. Guggenheim upped their target price on Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research report on Monday, June 30th. Needham & Company LLC reaffirmed a "buy" rating and set a $70.00 target price on shares of Tempus AI in a research report on Wednesday, May 7th. Finally, Piper Sandler upped their target price on Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a research report on Thursday, May 15th. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $65.09.

Tempus AI Price Performance

Tempus AI stock traded up $0.33 during mid-day trading on Friday, hitting $60.98. 8,333,428 shares of the company were exchanged, compared to its average volume of 7,727,344. The company has a quick ratio of 1.56, a current ratio of 1.71 and a debt-to-equity ratio of 2.45. The business has a fifty day moving average of $63.06 and a 200 day moving average of $55.80. Tempus AI, Inc. has a 1-year low of $31.36 and a 1-year high of $91.45. The company has a market capitalization of $10.56 billion and a PE ratio of -7.82.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, beating analysts' consensus estimates of ($0.27) by $0.03. The company had revenue of $255.74 million during the quarter, compared to analyst estimates of $248.13 million. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The firm's revenue for the quarter was up 75.4% on a year-over-year basis. As a group, sell-side analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.